- ISIN: CA29410K1084
- WKN: A0JMA0
- VALOR: 861924
EnWave Corporation offers industrial-scale dehydration technology for commercial applications in the food and pharmaceutical spaces. EnWave's proprietary Radiant Energy Vacuum ("REV™") platforms offer flexible, efficient processing suitable for food products and biomaterials. EnWave's mission is to establish its REV™ technology as the new global dehydration standard: faster and cheaper than freeze drying, with better quality than air drying or spray drying.
Introduction of a global standard for dehydration and replacement of the expensive deep frozen dehydration. REV Tecnology is faster and more cost effective than depp frozen dehydration and the product has a much higher quality and texture than the normal air or spray drying. EnWave wants to start to generate significant revenues in 2014 and wants to be profitable in 2015.
744 West Hastings Street, Suite 425
Canada, Vancouver V6C 1A5
|Mr. John Philip Adrian Budreski||Exec. Chairman||1958||75.172k|
|Mr. Daniel Henriques CPA, CA||Chief Financial Officer and Corp. Sec.||N/A||112.758k|
|Mr. Brent Charleton B.A., CFA, Dip.Tech., CSC||CEO & Pres||N/A||N/A|
|Mr. Leon Fu||Sr. VP of Manufacturing & Chief Engineer||N/A||N/A|
|Dr. Richard Mitchell||Sr. VP of Pharmaceutical Bus. Devel.||N/A||N/A|
Chart EnWave Corp.
Stock exchanges der EnWave Corp.
|Börse||Symbol||Letzter Kurs||Vortag||Veränderung||Volumen||Marktkap.||Aktien im Umlauf||Float Shares||Geld||Brief||Letzte Aktualisierung|
Finanzdaten der EnWave Corp.
Weitere Information folgen bald